Sera PrognosticsDecember 9, 2024Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting
ConformalOctober 2, 2024Conformal Medical Announces Launch of the GLACE Study with Next-Gen CLAAS® AcuFORM™ Left Atrial Appendage Occlusion Device
VenovaSeptember 4, 2024Venova Medical Announces $30 Million Series B Financing and Appointment of New Board Member
PanTher TherapeuticsAugust 13, 2024PanTher Therapeutics Receives FDA Clearance of IND Application for Phase 1b Study of PTM-101 for the Localized Treatment of Pancreatic Cancer
Sera PrognosticsJuly 1, 2024Sera Prognostics Added to Russell 2000 and 3000 Indexes Following Conclusion of 2024 Indexes Annual Reconstitution
EpitelJune 26, 2024Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors
Brixton BiosciencesMay 14, 2024Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
EpitelApril 23, 2024Epitel Receives FDA 510(k) Clearance for Two New Technologies: REMI Remote EEG Monitoring System for Ambulatory Use and REMI Vigilenz AI For Event Detection
AviveApril 18, 2024Avive Solutions Raises $56.5M in Growth Funding To Build Connected AED Network and Transform Cardiac Arrest Emergency Response in Communities Nationwide
Sera PrognosticsDecember 6, 2023Sera Prognostics Announces Primary Endpoint Criteria Met in Pivotal Prime Study Interim Look – Enrollment to Stop Due to Success
Brixton BiosciencesOctober 26, 2023BRIXTON BIOSCIENCES’ COOLIO™ THERAPY GRANTED BREAKTHOUGH DEVICE DESIGNATION BY FDA
